Join the "Targeted Prostate Biopsy with MRI–Ultrasound Fusion" webinar on 26 March at 7 pm, and learn more about MRI–ultrasound fusion technology.
Targeted prostate biopsy using MRI–ultrasound fusion has emerged as a key technique for improving the detection of clinically significant prostate cancer. By integrating multiparametric MRI with real time transrectal ultrasound, this approach enhances lesion localization, reduces sampling error, and increases diagnostic accuracy compared with conventional systematic biopsy.
In this webinar, made possible by the Canon Medical Academy, Prof. Carlos Nicolau will review fusion technology, procedural workflow, clinical evidence, and practical considerations of this biopsy approach.
Don't miss this opportunity to get practical insights from an expert in the field.
March 26 | 7PM CET
Discover More About the Moderator
Discover More About the Speaker
Ms. Alba Iruela Sánchez, MSc Alba Iruela Sánchez is a Biomedical Engineer with experience as a Clinical Scientist, supporting scientific collaborations with hospitals and clinical partners. She currently works as Magnetic Resonance Business Manager Iberia at Canon Medical Systems.
Disclaimers
© CANON MEDICAL SYSTEMS EUROPE B.V.
© CANON MEDICAL SYSTEMS EUROPE B.V.